Chernett Jorey 4
4 · Oncology Institute, Inc. · Filed Mar 23, 2026
Research Summary
AI-generated summary of this filing
Oncology Institute (TOI) 10% Owner Chernett Jorey Buys 25,000 Shares
What Happened
Chernett Jorey, listed as a 10% owner of Oncology Institute, Inc. (TOI), purchased 25,000 shares on 2026-03-20 in open-market/private purchase transactions. The filing reports a weighted average price of $3.35 per share, for a total value of $83,750. This was a purchase (code P), which investors often view as a more informative action than routine sales.
Key Details
- Transaction date: 2026-03-20; Form 4 filed: 2026-03-23 (filed within the 2-business-day Form 4 window).
- Reported price: weighted average $3.35 per share; total value $83,750.
- Price range: purchases occurred at prices ranging from $3.33 to $3.35 (footnote clarifies multiple transaction prices).
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- Footnote: The $3.35 figure is a rounded weighted average; Mr. Chernett can provide a breakdown of shares bought at each price on request.
- Insider status: Chernett Jorey is a 10% owner — a significant shareholder but not necessarily an executive.
Context
Purchases by insiders or large owners can signal confidence in the company, but they do not guarantee future performance. For 10% owners, purchases typically reflect investment/ownership decisions rather than compensation-related activity. This filing shows an outright purchase rather than an option exercise, gift, or award.
Insider Transaction Report
- Purchase
Common Stock
[F1]2026-03-20$3.35/sh+25,000$83,750→ 10,276,929 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.33 to $3.35, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.